Ophthalmology

Novel Port Delivery System With Ranibizumab Approved in Wet AMD

October 25th 2021, 5:00pm

Article

The first-of-its-kind port delivery system with ranibizumab serves as the first wet age-related macular degeneration (AMD) treatment in 15 years to provide an alternative to frequent eye injections.

Ranibizumab Linked With Extensive Lapses in Care for Proliferative Diabetic Retinopathy

October 23rd 2021, 3:00pm

Article

Approximately half of patients with proliferative diabetic retinopathy exhibited long lapses in care when prescribed ranibizumab across a 5-year follow-up.

Ophthalmology Overview: First Nasal Spray for Dry Eye Disease, Surgical Outcomes in Pediatric Patients, and More

October 21st 2021, 5:30pm

Article

Highlighting the latest ophthalmology-related news reported across MJH Life Sciences™.

Ophthalmology Overview: How Chronic Pain Impacts the Cornea, Dry Eye Disease in Postmenopausal Women, and More

October 14th 2021, 7:00pm

Article

Highlighting the latest ophthalmology-related news reported across MJH Life Sciences™.

Study Finds Significant Price Transparency Concerns for Ophthalmologic Procedures

October 11th 2021, 5:30pm

Article

An evaluation of price transparency tools for ophthalmologic procedures found significant usability, availability, and variability issues, which may disproportionately impact vulnerable populations.

Ophthalmology Overview: Novel Technology for Dry Eye Disease, Causes of Macular Degeneration, and More

October 7th 2021, 1:00pm

Article

Highlighting the latest ophthalmology-related news reported across MJH Life Sciences™.

Young-Onset Type 2 Diabetes Linked With Higher Risk of Retinopathy in Men

October 5th 2021, 6:30pm

Article

Male patients with young-onset type 2 diabetes were found to be at 72% greater risk of retinopathy compared with those who received a diagnosis at 50 years or older.

Ophthalmology Overview: Virtual Training for Diabetic Retinopathy, Impact of Blurry Vision, and More

September 30th 2021, 8:00pm

Article

Highlighting the latest ophthalmology-related news reported across MJH Life Sciences™.

Insulin Pump Use Linked With Decreased Risk of Diabetic Retinopathy in Young Patients With T1D

September 28th 2021, 5:30pm

Article

Risk of diabetic retinopathy (DR) was found to be decreased in young patients with type 1 diabetes (T1D) who were treated with insulin pumps, with findings also indicating a 2.1-fold greater risk of DR in Black participants compared with White individuals.

Dr Rajesh Rajpal on the Future of Eye Lens Technology, Cataract Surgery

September 24th 2021, 3:00pm

Video

Rajesh Rajpal, MD, chief medical officer, global head of clinical medical affairs, Johnson & Johnson Vision, addresses ongoing and future innovations in eye lens technology and instruments for cataract surgery.